AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $466,192 | -22.9% | 59,999 | -4.0% | 0.39% | -14.9% |
Q2 2023 | $604,990 | -14.4% | 62,499 | -3.1% | 0.46% | -17.4% |
Q1 2023 | $706,909 | +336.4% | 64,499 | +72.0% | 0.55% | +351.6% |
Q4 2022 | $161,996 | -42.6% | 37,499 | 0.0% | 0.12% | -49.4% |
Q3 2022 | $282,000 | -25.2% | 37,499 | 0.0% | 0.24% | -20.5% |
Q2 2022 | $377,000 | -18.8% | 37,499 | 0.0% | 0.30% | -2.3% |
Q1 2022 | $464,000 | -59.8% | 37,499 | -25.7% | 0.31% | -57.7% |
Q4 2021 | $1,155,000 | +3.2% | 50,499 | -0.1% | 0.73% | -11.2% |
Q3 2021 | $1,119,000 | +82.2% | 50,569 | +6.8% | 0.82% | +82.7% |
Q2 2021 | $614,000 | +172.9% | 47,354 | +191.1% | 0.45% | +133.7% |
Q4 2020 | $225,000 | -6.2% | 16,266 | 0.0% | 0.19% | -10.6% |
Q3 2020 | $240,000 | -13.4% | 16,266 | -4.4% | 0.22% | -28.9% |
Q2 2020 | $277,000 | +12.6% | 17,016 | 0.0% | 0.30% | +2.4% |
Q1 2020 | $246,000 | -29.7% | 17,016 | -1.7% | 0.30% | -20.6% |
Q4 2019 | $350,000 | – | 17,316 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |